TerrAscend Corp.

TSX:TSND.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.52 -1.61%

-$0.02 today

Market cap
$193.65M
Beta
2.04
P/E (TTM)
-2.5
EPS (TTM)
-$0.26
52W Low $0.33High $2.00

Volume 0.26M

Average 0.31M

TSND.TO Deferred Tax Liabilities

Taxes owed in future periods because of timing differences between accounting and tax rules.

TerrAscend Corp.TSX: TSND.TO

Deferred Tax Liabilities · Q1 FY2026 · quarter ended Mar 2026

Deferred tax liabilities falls 6.2% from a year ago

Deferred tax liabilities stood at $8.33M at the end of Q1 FY2026, down 6.2% from a year earlier and down 54.9% from the prior quarter. Over 3 fiscal years it compounded at -32.3% a year.

Context

  • Deferred tax liabilities amounted to 1.5% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Deferred tax liabilities increased in 1 of the last 3 fiscal years.

What to watch

Whether deferred tax liabilities keeps falling in the next quarterly balance sheet after a -6.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$8.33M-54.9% QoQ
Last fiscal yearDec 2025
$18.48M+119.3% YoY
Year agoMar 2025
$8.89M-6.2% since
Deferred Tax Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-6.2%——
1 year+119.3%——
3-year CAGR-32.3%——
5-year CAGR——
10-year CAGR——

Deferred Tax Liabilities history

USD · from the balance sheet

Latest · FY2025
18.48M USD
Year-over-year change
+119.3%
4-year CAGR
+6.7%

Deferred Tax Liabilities vs competitors

How TSND.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so deferred tax liabilities is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -6.2% is the 2nd highest of 5, against a peer median of -65.4%.
  • Deferred tax liabilities amounts to 1.5% of total assets for TSND.TO, versus a peer median of 0.0%.
TSND.TO Competitors
Deferred Tax Liabilities for TSND.TO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
DR.TOMedical Facilities CorporationMar 2026$18.04M USD+19.4%-3.5%6.5%
TSND.TOTerrAscend Corp.Mar 2026$8.33M USD-6.2%-32.3%1.5%
WEED.TOCanopy Growth CorporationMar 2026CA$8.2M CAD——0.7%
HLS.TOHLS Therapeutics Inc.Mar 2026$2.86M USD-30.7%+75.4%2.2%
EPRX.TOEupraxia Pharmaceuticals Inc.Mar 2026$0 USD——0.0%
FRX.TOFennec Pharmaceuticals Inc.Mar 2026$0 USD——0.0%
ACB.TOAurora Cannabis Inc.Mar 2026CA$0 CAD-100.0%—0.0%
XLY.TOAuxly Cannabis Group Inc.Mar 2026CA$0 CAD——0.0%
CPH.TOCipher Pharmaceuticals Inc.Mar 2026$0 USD——0.0%
OGI.TOOrganiGram Holdings Inc.Mar 2026CA$0 CAD-100.0%—0.0%
Peer median (excluding TSND.TO) —-65.4%+36.0%0.0%

Competitors are the stored peer set for TSND.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents100.55M36.31M22.24M26.38M37.46M
Short-term Investments03.63M1.91M1.73M361.34K
Net Receivables12.38M22.66M19.05M27.15M16.87M
Inventory35.79M46.75M51.68M48.8M33.99M
Other Current Assets38.88M7.55M8M373.79K21.23M
Total Current Assets171.05M123.1M102.89M104.43M109.91M
Property, Plant & Equipment (Net)178.79M332.78M239.66M324.13M156.34M
Goodwill89.57M91.15M106.93M153.73M109.57M
Intangible Assets167.02M241.88M215.85M243.84M167.01M
Long-term Investments68.05M0609.48K00
Tax Assets5.01M0(609.48K)19.21M10.47M
Other Non-current Assets8.47M120.6M1.19M(238.26M)13.54M
Total Non-current Assets516.92M786.41M563.63M502.8M456.93M
Total Assets734.69M951.93M666.52M607.23M566.83M
Account Payables27.69M44.35M49.9M46.73M37.57M
Short-term Debt8.26M52.02M137.74M6.76M17.16M
Tax Payables12.15M31.31M6.3M11.53M0
Deferred Revenue1.35M3.98M4.15M5.13M3.99M
Other Current Liabilities13.49M7.55M717K887K14.21M
Total Current Liabilities65.64M139.15M207M78.53M79.79M
Long-term Debt169.74M147.17M68.9M192.58M210.36M
Deferred Tax Liabilities14.27M59.6M17.18M8.43M18.48M
Deferred Revenue (Non-current)067.1M000
Other Non-current Liabilities84.17M3.31M104.09M107.7M130.87M
Total Non-current Liabilities284.41M329.04M218.78M351.89M388.21M
Total Liabilities445.64M516.16M425.78M430.41M467.99M
Common Stock00000
Retained Earnings(312.03M)(623.86M)(928.51M)(778.51M)(863.17M)
Accumulated OCI2.8M2.1M1.8M3.01M1.98M
Other Stockholders Equity00573.16K00
Minority Interest6.78M3.22M(2.33M)(207.1K)1.53M
Total Equity289.05M435.77M240.74M176.82M98.84M
Total Debt209.67M248.25M255.7M246.18M256.49M
Net Debt166.39M298.58M233.46M219.8M219.03M

TerrAscend Corp.

TSX:TSND.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.